TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT01039363

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Salvage reinduction chemotherapy including Gemtuzumab ozogamicin, Idarubicin and Cytarabine and Vorinostat
Description: Salvage reinduction therapy:~Vorinostat 200mg BID po (D1-14) Gemtuzumab ozogamicin 3 mg/m2 once (D1) Idarubicin 12mg/m2 for 2 days (D2-3) Cytarabine 500mg/m2 bid IV for 5 days (D2-6)~Maintenance:~Once achieved CR, then Vorinostat 200mg BID po for 2 weeks, then 1 week's rest (1 cycle) for 11 cycles~* Vorinostat should be stopped at least 2 weeks ahead of starting of consolidation therapy.~* Gemtuzumab will be omitted in a consolidation schedule.~* Allogeneic hematopoietic stem cell transplantation (HSCT) can be performed if HLA-matched sibling or unrelated donor is available. Vorinostat will be stopped 2 weeks prior to starting of conditioning regimen for allogeneic HSCT.
Study: NCT04349930

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cannabidiol vaginal suppository
Description: Cannabidiol vaginal suppository

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo vaginal suppository
Description: Placebo vaginal suppository
Study: NCT05650229

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KL1333
Description: Twice daily

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Twice daily
Study: NCT05395169

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: dietary supplement ,electronic treadmill ,DASH diet.
Description: Control group Will be receive medical treatment for 12 weeks. Study group Will be receive the same medication as in control group in addition to DASH diet and aerobic exercise for 12 weeks.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: dietary supplement ,electronic treadmill ,DASH diet.
Description: Control group Will be receive medical treatment for 12 weeks. Study group Will be receive the same medication as in control group in addition to DASH diet and aerobic exercise for 12 weeks.
Study: NCT05414968

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Non-pharmacological Heat, Pressure, and Vibration
Description: The innovation central to this approach is in the multifactorial combination of pressure, heat, and vibration stimuli to improve foot sensation. The heat stimuli will be provided with commercially available heating elements. The pressure stimuli will be provided via pneumatic garment. Lastly, the vibrotactile stimuli will be provided with commercially available vibrotactile motors. The non-pharmacological DPN device will be able to safely and consistently control temperature to 100-105°F within 1°F, control pressure to 50 mmHg within 5 mmHg at 0.25 Hz, and provide 5 distinguishable vibrational stimuli to 5 zones on the leg and foot.
Study: NCT05112588

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intervention
Description: The women randomized to intervention will get support from the Child Health Care unit (CHCU) at every visit with the baby. Before the visit the women will have blood-samples taken and waist and weight measured. The women will also get support from a digital solution, specially developed for this purpose (MyMOWO). The nurse at the CHCU will include information and support to the mother at every visit accort´ding to a special protocol. All women will be carefully examined at baseline, after one and four years will blood-tests, anthropometric measurements and maximal oxygen uptake (VO2max).
Study: NCT06640335

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 20 min preload
Description: Subjects consume 200 g baby round spinach supplemented with canola oil first, wait 20 minutes, then consume 300 g of mashed potatoes.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Spinach only / 10 min preload
Description: Subjects consume 200 g baby round spinach WITHOUT canola oil first, wait 10 minutes, then consume 300 g of mashed potatoes.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Canola oil only / 10 min preload
Description: Subjects consume 20 g of canola oil first, wait 10 minutes, then consume 300 g of mashed potatoes.
Study: NCT05430659

Intervention type: OTHER
Intervention: observational study
Description: Retrospective observational study

Intervention type: OTHER
Intervention: observational study
Description: Retrospective observational study
Study: NCT05222802

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ERAS-801
Description: Administered orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ERAS-801
Description: Administered orally
Study: NCT05526183

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Adeno-viral vector vaccine
Description: The vaccine will be injected intramuscularly, as two doses 28 days apart. Two different dosages will be given to volunteers (low dose: 5x1010 and high dose: 1x1011)

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Adeno-viral vector vaccine
Description: The vaccine will be injected intramuscularly, as two doses 28 days apart. Two different dosages will be given to volunteers (low dose: 5x1010 and high dose: 1x1011)
Study: NCT06172283

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intermittent Fasting
Description: Dietary intervention
Study: NCT05471947

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 15% Trichloroacetic acid + 3% glycolic acid
Description: Treatment of the hand with an over-the-counter chemical peel containing 15% trichloroacetic acid + 3% glycolic acid
Study: NCT05234788

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Transfemoral Renal Denervation
Description: Radiofrequency renal denervation using the Iberis Renal Denervation System treated via femoral artery access

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Transradial Renal Denervation
Description: Radiofrequency renal denervation using the Iberis Renal Denervation System treated via radial artery access
Study: NCT06319976

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: open chain exercises for rotator cuff muscles
Description: open chain exercises for rotator cuff muscles, three times per week for six weeks.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Advices for postural correction
Description: Advices for postural correction like neutral position of head and neck, aliening the shoulder and hip and using a foot stool to rest the feet.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Advices for postural correction
Description: Advices for postural correction like neutral position of head and neck, aliening the shoulder and hip and using a foot stool to rest the feet.
Study: NCT05686694

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Video Education
Description: Sharing of Planned Education Videos on Instagram In this research, the platform where planned video education will be shared was determined as Instagram, which is the most used social media platform by pregnant women. In the Instagram user name @ogttegitim account, 6 education videos that will be created and shared.
Study: NCT06042738

Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: proxeed plus
Description: Group 1 was recommended to receive a food supplement containing 2000 mg L-carnitine, 2000 mg fructose, 932 mg acetyl L-carnitine, 225 mg vitamin C, 115 mg citric acid, 50 mg coenzyme Q10, 14 mg zinc, 115 µg selenium, 3750 µg vitamin B12 and 500 µg folic acid as one sachet in the morning and evening
Study: NCT05276635

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: The Sleep Hygiene Education (SHE)
Description: Patients were randomized into two equal groups of 30 participants each. One group received a Sleep Hygiene Education (SHE) intervention

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Emotional Freedom Techniques (EFT)
Description: 30 participants had a form of Emotional Freedom Techniques (EFT) adapted for use with insomnia (EFT-I).
Study: NCT05696197

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Targeted touchscreen training
Description: Participants will practice the Swipe Slide Pattern (SSP) task independently at home in both ST and DT condition, offered in a random order. During this task, participants form different pre-defined patterns by moving their finger over a touchscreen, resembling a touchscreen unlock trace. The DT condition includes the SSP-task while counting either red or green lights illuminated on the screen. They will receive 10 training sessions of the SSP-task over a period of two weeks. Each week will consist of 5 consecutive days of training for approximately 10 minutes per session. Participants will perform 9 trials of 12 patterns each, alternated with rest periods of 14 seconds. Instruction and answers are also included. Feedback will be provided by means of knowledge of performance. On each training day, participants will receive a reminder on the training tablet.
Study: NCT05536141

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: casdatifan
Description: Administered as specified in the treatment arm

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: casdatifan
Description: Administered as specified in the treatment arm

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: casdatifan
Description: Administered as specified in the treatment arm

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: casdatifan
Description: Administered as specified in the treatment arm

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: casdatifan
Description: Administered as specified in the treatment arm
Study: NCT06251388

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AK104
Description: AK104（10.0 mg/kg，intravenous (IV) infusion，Q3W）maintained with no more than 1 year.
Study: NCT05948878

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Novel Taping Method
Description: Subjects will be asked to have the novel taping method placed on their left and right antecubital fossa region, superficially taping an IV catheter.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Novel Taping Method
Description: Subjects will be asked to have the novel taping method placed on their left and right antecubital fossa region, superficially taping an IV catheter.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: BCH Emergency Department Taping Method
Description: Subjects will be asked to have the BCH emergency department taping method placed on their left and right antecubital fossa region, superficially taping an IV catheter.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: BCH Emergency Department Taping Method
Description: Subjects will be asked to have the BCH emergency department taping method placed on their left and right antecubital fossa region, superficially taping an IV catheter.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Chevron Taping Method
Description: Subjects will be asked to have the Chevron taping method placed on their left and right antecubital fossa region, superficially taping an IV catheter.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Chevron Taping Method
Description: Subjects will be asked to have the Chevron taping method placed on their left and right antecubital fossa region, superficially taping an IV catheter.
Study: NCT05536141

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: casdatifan
Description: Administered as specified in the treatment arm
Study: NCT05946252

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Motor imagery
Description: Motor imagery will be performed according to the PETTLEP (Physical,Environment,Task,Time,Learn,Emotion,Perspective) model for 15 minutes.~1. To imagine walking activity in different environments (seaside, beach, walking path).~2. The rest activity will be imagined by sitting on a bench.~3. Upper extremity strengthening exercises with dumbbells, lower extremity strengthening exercises with elastic band and trunk-oriented bridging, posterior pelvic tilt and table top stabilization exercises will be visualized.~4. The rest activity will be imagined by sitting on a bench.~5. Imagination will end with homecoming and domestic activities.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Diaphragmatic breathing
Description: Diaphragmatic breathing will be shown to pregnant women in the supine position, eyes closed, with one hand on the chest and the other hand on the abdomen. This practice will last for five minutes.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Diaphragmatic breathing
Description: Diaphragmatic breathing will be shown to pregnant women in the supine position, eyes closed, with one hand on the chest and the other hand on the abdomen. This practice will last for five minutes.
Study: NCT05536141

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: casdatifan
Description: Administered as specified in the treatment arm

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: casdatifan
Description: Administered as specified in the treatment arm
Study: NCT06626815

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Lateral Kangaroo Position
Description: Newborns in the lateral kangaroo position group will be positioned diagonally on their mothers chests, with their heads placed between the mothers breast and collarbone.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Reverse Kangaroo Position
Description: Newborns in the reverse kangaroo position group will be positioned vertically with their backs in contact with the mothers chest.
Study: NCT06626555

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Letermovir
Description: Letermovir 480mg PO once daily
Study: NCT06690411

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mulligan Concept
Description: The participants of the Mulligan SNAG group will undergo the Mulligan SNAG technique. Mulligan's SNAG technique is a gentle manual therapy method. This technique is based on the correction of the joint position. There are 3 techniques specified for headache; Headache SNAG, Reverse Headache SNAG, and C1-C2 SNAG.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Myofascial Release Technique
Description: Myofascial therapy can be described as massage-type manual therapy. The participants of the Myofascial Release Group will undergo the myofascial release technique.
Study: NCT06415903

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TQB3117 tablets
Description: TQB3117 is a protein inhibitor.
Study: NCT05113953

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Centanafadine
Description: Sustained-release oral tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Centanafadine
Description: Sustained-release oral tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Oral tablets

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Oral tablets
Study: NCT06015958

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Streptococcus salivarius M18 toothpaste (1 million cfu)
Description: Probiotics Streptococcus salivarius M18 toothpaste 1 million cfu/g~In this study, a toothpaste formulation containing S. salivarius M18 will be evaluated for its potential for delivering the probiotic to the oral cavity.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Streptococcus salivarius M18 toothpaste (10 million cfu)
Description: Probiotics Streptococcus salivarius M18 toothpaste 10 million cfu/g~In this study, a toothpaste formulation containing S. salivarius M18 will be evaluated for its potential for delivering the probiotic to the oral cavity.
Study: NCT05790772

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Vigorous Exercise
Description: 50 minutes of running on a treadmill
Study: NCT06262269

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Home-based adapted physical activity program supervised by an APA teacher via individual video conference.
Description: Participants will follow a 12-week tele-rehabilitation programme involving high-intensity interval training (HIIT) adapted to their AIS. The programme includes three 45-minute individual sessions per week. The exercises are selected from a database designed for AIS patients. The APA teacher will systematically document the patient's presence or absence at each tele-rehabilitation session, thus assessing their adherence to the programme.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: First period of the home-based adapted physical activity program with an exercise booklet.
Description: Participants will receive a self-programme in the form of a booklet of specific HIIT-type exercises adapted to their AIS. The programme is to be carried out at home over a 12-week period, with 3 45-minute sessions per week. The exercises are taken from the same database. Each participant in the CONTROL group will be encouraged to keep a follow-up diary, noting the date, start time and end time of each session (in order to assess adherence to the sessions).

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Second period of the home-based adapted physical activity program with an exercise booklet.
Description: Participants will receive a self-programme in the form of a booklet containing specific HIIT-type exercises adapted to their AIS. The programme is to be carried out at home over a 12-week period, with 3 45-minute sessions per week. The exercises are taken from the same database. Each participant in the CONTROL group will be encouraged to keep a follow-up diary, noting the date, start time and end time of each session (in order to assess adherence to the sessions).

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Second period of the home-based adapted physical activity program with an exercise booklet.
Description: Participants will receive a self-programme in the form of a booklet containing specific HIIT-type exercises adapted to their AIS. The programme is to be carried out at home over a 12-week period, with 3 45-minute sessions per week. The exercises are taken from the same database. Each participant in the CONTROL group will be encouraged to keep a follow-up diary, noting the date, start time and end time of each session (in order to assess adherence to the sessions).
Study: NCT05609981

Intervention type: OTHER
Group type: OTHER
Intervention: Clinical medication review focused on deprescribing
Description: A pharmacist-led intervention consisting of a clinical medication review with the focus on deprescribing in older patients using multidose drug dispensing (MDD) systems.~Pharmacist are trained in deprescribing and a developed toolbox to support the intervention is provided
Study: NCT04708028

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dog Therapy
Description: The intervention is a therapy dog interaction (e.g. petting) for up to 2 minutes before their appointment and first interaction with the doctor. The subject can pet the dog for as long as they like up until the 2 minute mark.
Study: NCT05913128

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Glandular Urethral Disassembly technique
Description: For Primary Distal Hypospadius Repair

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Glandular Urethral Disassembly technique
Description: For Primary Distal Hypospadius Repair
Study: NCT05536141

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: casdatifan
Description: Administered as specified in the treatment arm

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cabozantinib
Description: Administered as specified in the treatment arm
Study: NCT05128617

Intervention type: DRUG
Intervention: Epirubicin-cyclophosphamide
Description: 1 cycle of Epirubicin-cyclophosphamide

Intervention type: DRUG
Intervention: Paclitaxel
Description: 1 cycle of Paclitaxel
Study: NCT06094023

Intervention type: OTHER
Intervention: Food Frequency Questionnaire
Description: Food frequency questionnaires (FFQs) are a common method for measuring dietary intake in large epidemiological studies, in particular in low literacy settings were diaries and food history would not be viable.

Intervention type: OTHER
Intervention: 24 Hour food recall
Description: Standardized and validated approach of collecting all foods, beverages, and supplements consumed during the past 24 hours.
Study: NCT05652257

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [14C]-brensocatib
Description: Oral solution.
Study: NCT06627218

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prothrombin Complex Concentrate
Description: Adhere to Recommendations for PCC Management in Major Bleeding Following Trauma
Study: NCT06628128

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JNT-517 Tablet
Description: JNT-517: 75 mg BID

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JNT-517 Tablet
Description: JNT-517: 75 mg BID

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JNT-517 Tablet
Description: JNT-517: 75 mg BID

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JNT-517 Tablet
Description: JNT-517: 75 mg BID
Study: NCT06709222

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: robotic rehabilitation
Description: robotic rehabilitation

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: robotic rehabilitation
Description: robotic rehabilitation

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: exercise
Description: dual-task exercises
Study: NCT04723537

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Part A: Upamostat 200 mg
Description: 1 capsule comprising 200 mg of upamostat and 1 capsule comprising matching placebo.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Part A: Upamostat 400 mg
Description: 2 capsules, each capsule comprising 200 mg of upamostat

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Part A and B: Placebo
Description: 1 or 2 capsules, each capsule a matching placebo

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Part A and B: Placebo
Description: 1 or 2 capsules, each capsule a matching placebo

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Part B: Upamostat 200 or 400 mg
Description: Based on dose selection from Part A, Part B Upamostat will be EITHER a single 200 mg dose of upamostat OR two 200 mg doses of upamostat, for a total of 14 days.
Study: NCT05606705

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Baked Milk
Description: Participants to regularly eat a baked milk muffin for 6 weeks
Study: NCT05899725

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Corticosteroids
Description: Initial dosage of corticosteroids is no less than predinisone 1mg/kg/d or other corticosteroids with equal equivalence

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Corticosteroids and Ruxolitinib
Description: Initial dosage of corticosteroids is no less than predinisone 1mg/kg/d or other corticosteroids with equal equivalence, add-on oral Ruxolitinib 5mg twice a day for 2 weeks, following with Ruxolitinib
Study: NCT05771571

Intervention type: OTHER
Group type: OTHER
Intervention: Functional olive oil, enhanced with orange peel extract
Description: The functional olive oil was enriched with 10% w/w orange peel extract

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Control
Description: Refined olive oil